UNIVERSAL HEALTH SERVICES INC (UHS) Form 8-K — Oct 27, 2026
Universal Health Services reported Q3 2026 net income of $308.7 million, or $5.22 per diluted share, down from $373.0 million, or $5.86, a year ago, as Adjusted EBITDA fell to $624.6 million from $670.6 million. Net revenues rose 5.3% to $4.733 billion and nine-month operating cash flow climbed 14.9% to $1.481 billion. Results included a $47 million pre-tax benefit from Medicaid supplemental payment programs (Washington, D.C. and California) and a $26 million pre-tax charge tied to a tentative settlement of the Cumberland Hospital litigation, where a 2024 jury awarded three plaintiffs roughly $360 million before reductions.
Key figures
- Eps
- 5.22
- Revenue
- 4733352000
- Net Income
- 308684000
- Total Debt
- 5707341000
- Revenue Yoy
- 5.3%
- Total Assets
- 17185766000
- Cash Position
- 168749000
- Debt to ebitda
- 2.07
- Nine month eps
- 16.86
- Prior year eps
- 5.86
- Q3 buyback cost
- 242100000
- Ytd buyback cost
- 689600000
- Q3 buyback shares
- 1350000
- Adjusted ebitda q3
- 624645000
- Nine month revenue
- 13866546000
- Prior year net income
- 372957000
- Operating cash flow 9m
- 1481487000
- Adjusted ebitda q3 prior year
- 670600000
- Litigation reserve increase pretax
- 26000000
- Remaining repurchase authorization
- 735400000
- Medicaid supplemental favorable pretax
- 47000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.